Ethiopia Health News API

{
    "totalArticles": 1771,
    "articles": [
        {
            "id": "d9d7a9f5f3a4e12c300681119c9c5999",
            "title": "New MS initiative gives patients a louder voice in research priorities",
            "description": "A new community-led network called PRADA enables underrepresented patients living with MS to help set research priorities.",
            "content": "The Accelerated Cure Project for Multiple Sclerosis (ACP) has launched a new community-led initiative designed to ensure that people from underrepresented multiple sclerosis (MS) communities help set priorities for future MS research.\nsp\nThe initiati... [3375 chars]",
            "url": "https://multiplesclerosisnewstoday.com/news-posts/2026/02/24/new-ms-initiative-gives-patients-louder-voice-research-priorities/",
            "image": "https://multiplesclerosisnewstoday.com/wp-content/uploads/2026/02/iStock-2194401529-1200x630-cropped-center-top.jpg",
            "publishedAt": "2026-02-24T14:19:10Z",
            "lang": "en",
            "source": {
                "id": "a1b6d9ac23688889ceab2005a24d157c",
                "name": "Multiple Sclerosis News Today",
                "url": "https://multiplesclerosisnewstoday.com"
            }
        },
        {
            "id": "fceb783d0b5a5959a2479cba85639d72",
            "title": "Endangerment Finding, bird flu, what counts as professional degrees, and more",
            "description": "The Dose (Feb 24)",
            "content": "Northeast folks, I hope you have a lot of hot chocolate on hand. YLE team members are sending me pictures of snowbanks taller than small children. Stay strong! And be careful shoveling snow. (Not so fun fact: hundreds of thousands of people end up in... [10023 chars]",
            "url": "https://yourlocalepidemiologist.substack.com/p/endangerment-finding-bird-flu-what",
            "image": "https://substackcdn.com/image/fetch/$s_!FVpX!,w_1200,h_675,c_fill,f_jpg,q_auto:good,fl_progressive:steep,g_auto/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9eb5cbbc-f10f-498d-990b-1fd1bb917be9_1376x500.png",
            "publishedAt": "2026-02-24T14:17:53Z",
            "lang": "en",
            "source": {
                "id": "19a78775ff177fdcade1ea6749e91cb4",
                "name": "Your Local Epidemiologist",
                "url": "https://yourlocalepidemiologist.substack.com"
            }
        },
        {
            "id": "27289ad253b2e789d1770c96793c2916",
            "title": "[CROI 2026] Contagion Live: Switching to doravirine/islatravir maintains viral suppression through 96 weeks",
            "description": "In virologically suppressed adults with HIV, switching to once-daily doravirine/islatravir maintained high rates of viral suppression through 96 weeks.",
            "content": "Contagion Live news story\nNew 96-week data from the open-label, phase 3 MK-8591A-051 study demonstrate that switching to the fixed-dose combination of doravirine and islatravir (DOR/ISL, 100/0.25 mg) continues to support durable viral suppression and... [291 chars]",
            "url": "https://www.eatg.org/hiv-news/croi-2026-contagion-live-switching-to-doravirine-islatravir-maintains-viral-suppression-through-96-weeks/",
            "image": "https://www.eatg.org/wp-content/uploads/2023/11/f5b02e4d-add5-45fb-bdb0-4a48d0ea77af.jpg",
            "publishedAt": "2026-02-24T00:18:38Z",
            "lang": "en",
            "source": {
                "id": "323e897150d4f6ea4eb50b9db2f4fb89",
                "name": "European AIDS Treatment Group",
                "url": "https://www.eatg.org"
            }
        }
    ]
}